Search results for "brazil"
Article
Biomanufacturing Outsourcing Globalization Continues
Among the BRIC countries (Brazil, Russia, India, and China), China continues to lead the pack, followed by India.
In the short term, however, quality problems and perceptions continue to stunt Ind…
Article
Pharma Investments Reflect Key Industry Trends
…s expected to grow significantly, and in response to individual government requirements, such as in Brazil and Russia, for western manufacturers that want to sell products--both large and small-molec…
Article
Global Expansion Shapes Drug Oversight
Global expansion has been a prominent theme at the United States Pharmacopeia (USP), which now has offices and laboratories in India, China, and Brazil to provide local manufacturers with access to re…
Article
Bureaucratic Roadblocks Threaten Biopharma Growth
Furthermore, Brazil’s unprecedented review of patents by the health regulatory authority, China’s increased data requirements, and Canada’s increased utility requirements all ultimately undermine the …
Article
Gowning Practices Provide Clues to cGMP Compliance
Review gowning practices as a tool to evaluate cGMP compliance in a facility.
The foundation of any successful quality-assurance system is strict adherence to good manufacturing practices (GMP…
Article
Outsourcing Trends in Biopharmaceutical Manufacturing
Over the past decade, BioPlan has found that developing regions, including China, India, and Brazil, as well as the substantial investments in technologies that improve productivity and efficiency are…
Article
Drugs, At What Cost?
In emerging markets (more than 20 nations including China, Brazil, India, Russia, Mexico, and Turkey), growth will increase from $26 billion in 2012 to $30-50 billion in 2017, primarily due to increas…